Skip to content
Open in App
United Therapeutics logo

United Therapeutics

web2

United Therapeutics Corporation engages in the development and commercialization of products to...

Symbol · UTHR
Company profile

About

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

JD

Judy D. Olian

Independent Director

Company leadership profile.

MA

Martine A. Rothblatt

Founder, Chairman & CEO

Company leadership profile.

CP

Christopher Patusky

Independent Vice Chairman & Lead Independent Director

Company leadership profile.

CC

Christopher Causey

Independent Director

Company leadership profile.

RG

Richard Giltner

Independent Director

Company leadership profile.

LW

Louis W. Sullivan

Independent Director & Member of the Scientific Advisory Board

Company leadership profile.

RA

Raymond A. Dwek

Member of the Scientific Advisory Board

Company leadership profile.

RC

Raymond C. Kurzweil

Independent Director

Company leadership profile.

VJ

Victor J. Dzau

Director

Company leadership profile.

MH

Magdi H. Yacoub

Member of the Scientific Advisory Board

Company leadership profile.

TG

Thomas G. Thompson

Independent Director

Company leadership profile.

RC

Robert C. Bourge

Member of the Scientific Advisory Board

Company leadership profile.

NM

Nilda Mesa

Independent Director

Company leadership profile.

MG

Mardi Gomberg-Maitland

Member of the Scientific Advisory Board

Company leadership profile.

LM

Linda Maxwell

Independent Director

Company leadership profile.

JK

Jan K. Malcolm

Independent Director

Company leadership profile.

NM

Nancy Manley

Member of the Scientific Advisory Board

Company leadership profile.

KJ

Kevin J. Tracey

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated United Therapeutics.

Orbitrum research

Experts evaluating United Therapeutics

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment